COVID-19 assessment in family practice-A clinical decision rule based on self-rated symptoms and contact history.


Journal

NPJ primary care respiratory medicine
ISSN: 2055-1010
Titre abrégé: NPJ Prim Care Respir Med
Pays: England
ID NLM: 101631999

Informations de publication

Date de publication:
25 11 2021
Historique:
received: 19 04 2021
accepted: 27 10 2021
entrez: 26 11 2021
pubmed: 27 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

The study aimed to evaluate the diagnostic accuracy of contact history and clinical symptoms and to develop decision rules for ruling-in and ruling-out SARS-CoV-2 infection in family practice. We performed a prospective diagnostic study. Consecutive inclusion of patients coming for COVID-PCR testing to 19 general practices. Contact history and self-reported symptoms served as index test. PCR testing of nasopharyngeal swabs served as reference standard. Complete data were available from 1141 patients, 605 (53.0%) female, average age 42.2 years, 182 (16.0%) COVID-PCR positive. Multivariable logistic regression showed highest odds ratios (ORs) for "contact with infected person" (OR 9.22, 95% CI 5.61-15.41), anosmia/ageusia (8.79, 4.89-15.95), fever (4.25, 2.56-7.09), and "sudden disease onset" (2.52, 1.55-4.14). Patients with "contact with infected person" or "anosmia/ageusia" with or without self-reported "fever" had a high probability of COVID infection up to 84.8%. Negative response to the four items "contact with infected person, anosmia/ageusia, fever, sudden disease onset" showed a negative predictive value (NPV) of 0.98 (95% CI 0.96-0.99). This was present in 446 (39.1%) patients. NPV of "completely asymptomatic," "no contact," "no risk area" was 1.0 (0.96-1.0). This was present in 84 (7.4%) patients. To conclude, the combination of four key items allowed exclusion of SARS-CoV-2 infection with high certainty. With the goal of 100% exclusion of SARS-CoV-2 infection to prevent the spread of SARS-CoV-2 to the population level, COVID-PCR testing could be saved only for patients with negative response in all items. The decision rule might also help for ruling-in SARS-CoV-2 infection in terms of rapid assessment of infection risk.

Identifiants

pubmed: 34824286
doi: 10.1038/s41533-021-00258-4
pii: 10.1038/s41533-021-00258-4
pmc: PMC8617029
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Informations de copyright

© 2021. The Author(s).

Références

BMC Fam Pract. 2020 Dec 3;21(1):251
pubmed: 33272198
Sci Rep. 2021 Jun 14;11(1):12492
pubmed: 34127693
Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665
pubmed: 32633856
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600
Nat Commun. 2021 Jan 15;12(1):378
pubmed: 33452267
BMJ. 2020 Dec 22;371:m4907
pubmed: 33561814
Fam Pract. 2021 Mar 29;38(2):154-159
pubmed: 32914857
JAMA. 2020 Dec 1;324(21):2153-2154
pubmed: 33185688
Front Public Health. 2020 May 08;8:193
pubmed: 32574293
J Gen Intern Med. 2020 Aug;35(8):2502-2504
pubmed: 32519322
Nature. 2021 Feb;590(7845):202-205
pubmed: 33564189

Auteurs

Antonius Schneider (A)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany. antonius.schneider@tum.de.

Katharina Rauscher (K)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.

Christina Kellerer (C)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.

Klaus Linde (K)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.

Frederike Kneissl (F)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.

Alexander Hapfelmeier (A)

TUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Munich, Germany.
TUM School of Medicine, Institute of Medical Informatics, Statistics and Epidemiology, Technical University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH